2509 — Qyuns Therapeutics Co Balance Sheet
0.000.00%
- HK$2.49bn
- HK$2.45bn
- CNY158.79m
Annual balance sheet for Qyuns Therapeutics Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|
Period Length: | — | — | — | — |
Source: | PROSPECTUS | PROSPECTUS | ARS | PRESS |
Standards: | IFRS | IFRS | IFRS | — |
Status: | Final | Final | Final | Final |
Cash | ||||
Cash and Equivalents | ||||
Short Term Investments | ||||
Cash and Short Term Investments | 620 | 614 | 377 | 556 |
Net Total Receivables | 8.65 | 4.04 | 10.6 | — |
Total Inventory | ||||
Prepaid Expenses | ||||
Total Other Current Assets | ||||
Total Current Assets | 648 | 636 | 418 | 617 |
Gross Property, Plant And Equipment | ||||
Accumulated Depreciation | ||||
Net Property, Plant And Equipment | 406 | 389 | 363 | 334 |
Net Intangible Assets | ||||
Long Term Notes Receivable | ||||
Other Long Term Assets | ||||
Total Assets | 1,067 | 1,035 | 796 | 984 |
Accounts Payable | ||||
Payable / Accrued | ||||
Accrued Expenses | ||||
Notes Payable / Short Term Debt | ||||
Current Portion of Long Term Debt / Capital Leases | ||||
Total Other Current Liabilities | ||||
Total Current Liabilities | 69.7 | 122 | 252 | 430 |
Long Term Debt | ||||
Capital Lease Obligations | ||||
Total Long Term Debt | ||||
Total Debt | ||||
Deferred Income Tax | ||||
Minority Interest | ||||
Total Other Liabilities | ||||
Total Liabilities | 397 | 393 | 501 | 755 |
Common Stock | ||||
Additional Paid In Capital | ||||
Retained Earnings (Accumulated Deficit) | ||||
Total Equity | 670 | 642 | 295 | 229 |
Total Liabilities & Shareholders' Equity | 1,067 | 1,035 | 796 | 984 |
Total Common Shares Outstanding |